Optimization of Tyrosine Kinase Inhibitor-Loaded Gold Nanoparticles for Stimuli-Triggered Antileukemic Drug Release

Tyrosine kinase inhibitor (TKI) therapy is gaining attraction in advanced cancer therapeutics due to the ubiquity of kinases in cell survival and differentiation. Great progress was made in the past years in identifying tyrosine kinases that can function as valuable molecular targets and for the ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatar, Andra-Sorina, Nagy-Simon, Timea, Tigu, Adrian Bogdan, Tomuleasa, Ciprian, Boca, Sanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455807/
https://www.ncbi.nlm.nih.gov/pubmed/37623644
http://dx.doi.org/10.3390/jfb14080399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455807/
https://www.ncbi.nlm.nih.gov/pubmed/37623644
http://dx.doi.org/10.3390/jfb14080399

Ejemplares similares